Business Context and Reporting Period
This Form 8-K Current Report was filed by Herbalife Ltd. on October 25, 2013. The filing reports a corporate governance event: the appointment of Dr. Richard H. Carmona as a Class III director by the Board of Directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to director compensation:
- Annual Retainer: $70,000 per year.
- Equity Award: Stock-settled restricted stock units or stock appreciation rights with a grant date fair value of $110,000 (pro-rated for the partial service year).
Material Changes
The material change reported is the addition of Dr. Richard H. Carmona to the Board of Directors. No arrangement or understanding existed between Dr. Carmona and any other person regarding his appointment.
Guidance, Outlook, and Risks
The filing contains no management guidance, outlook, risk factors, or discussion of contingencies. It notes that a press release announcing the appointment was issued on October 28, 2013, and is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the pro-rated calculation of the $110,000 equity award based on the appointment date through the 2014 Annual General Meeting.
- Review the attached press release (Exhibit 99.1) for additional context on Dr. Carmona's background and qualifications.
- Confirm the effective date of the director's participation in the non-management compensation program.